Tourette syndrome is a neurological condition that has no cure but can be managed with various strategies—some of which are ...

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

In PEOPLE's exclusive sneak peek at an upcoming episode of TLC's 'Baylen Out Loud', Baylen decides to try Botox for the first ...

US CNS specialist Relmada Therapeutics has announced the acquisition of sepranolone, a Phase IIb ready neurosteroid, from ...

Tourette syndrome is currently diagnosed about three times more frequently in males than in females. A new study finds that female individuals are less likely to be diagnosed with the syndrome, take ...

Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.

Larry Biederman, a high school science teacher, talks to us about how he handles being a teacher with Tourette's syndrome.

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on an acquisition, study results ...

TLC seems particularly busy lately, announcing some new shows that take the channel in familiar directions and at least one ...

Relmada Therapeutics (RLMD) announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid, from Asarina Pharma AB, being developed ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement ...

Jake Duraski, a LaGrange resident, was recently featured on an episode of the show, Baylen Out Loud. The series follows ...